Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Historical Growth of the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market: Insights into Expanding Industry Size
The market size for raw materials used in the synthesis of messenger ribonucleic acid (mRNA) has seen a slight increase in the recent past. The growth is projected to move from $2.99 billion in 2024 to $3.03 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 1.5%.
This growth during the historical period can be traced back to advancements in biomedical research, an increased focus on vaccines and therapeutics, a rise in the demand for personalized medicine, readiness and response to outbreaks, and the development of the biotech industry.
The market size for the raw materials used in the synthesis of messenger ribonucleic acid (mrna) is anticipated to witness consistent growth in the coming years. It is projected to expand to $3.48 billion by 2029 with a compound annual growth rate (CAGR) of 3.5%.
Factors contributing to this anticipated growth during the forecast period include enhancements in supply chain, commercialization and market expansion strategies, investments in the biotech and pharmaceutical sectors, regulatory support and approvals, and broadening therapeutic applications. Key trends identified for this forecast period comprise of the entry of new players, enhanced quality control and standardization, intellectual property rights and licensing issues, worldwide access and equity, and a move towards more sustainable and scalable production methods.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Which Primary Drivers Are Boosting the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market’s Performance?
The escalating rates of cancer and chronic illnesses are anticipated to fuel the expansion of the mRNA synthesis raw materials market. Cancer, a disorder characterized by uncontrolled growth and potential spread of aberrant cells, alongside chronic diseases which persist for a year or more requiring ongoing medical care, interfere with daily activities or both, are fostering this growth.
mRNA synthesis raw materials, applied in drug discovery, vaccine advancement, and production of RNA-based therapeutics, provide improved immunogenicity, enhanced efficiency, and abbreviated production time to combat cancer and chronic diseases.
For example, the American Cancer Society Facts and Figures indicated that, in 2022, approximately 1.9 million fresh cancer cases were identified in the US, resulting in 609,360 fatalities.
Predictions for 2023 suggest a slight increase with over 1.9 million emerging cases and an estimated 609,820 deaths. Consequently, the increasing prevalence of cancer and chronic illnesses stimulates the synthesis of mRNA raw materials.
Which Key Segments Are Driving Growth in the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the Key Trends Forecasted to Reshape the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry Structure?
The emergence of product innovations is a primary trend gaining traction in the mRNA synthesis raw materials market. To cement their market standing, major firms in this sector are focusing on inventing cutting-edge products.
For example, Thermo Fisher Scientific, a US-based firm specializing in instrumentation, reagents, consumables, and software services announced the introduction of Dynabeads Solutions in September 2022. These beads are developed to scale the synthesis and purification of GMP-grade mRNA for vaccine production.
The use of Dynabeads Streptavidin for In Vitro Transcription makes the IVT of cell-free mRNA on a solid-phase more manageable and permits the re-usage of the DNA template for up to six times. That reduces the time and effort involved in plasmid design while also enhancing the mRNA yield on scales ranging from grams to grams.
Furthermore, it aids in crafting an efficient pipeline, enabling mRNA businesses to transition swiftly from the development stage to commercialization.
Which Geographies Are Leading the Expansion of the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market in 2025?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=12336
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
